Overview

Tolvaptan for Ascites in Cirrhotic Patients

Status:
Completed

Trial end date:
2015-01-01

Target enrollment:

Participant gender:

Summary

Open Label Study evaluating the safety and efficacy of tolvaptan in the treatment of ascites in liver cirrhosis. Tolvaptan will be administered in combination with current ascites management.

Phase:

Phase 4

Details

Lead Sponsor:

University of Florida

Collaborator:

Otsuka America Pharmaceutical

Treatments:

Tolvaptan